BiOptix Closes $9 Million Series B Funding
BiOptix, headquartered in Boulder, Colorado, seeks to expand the power of label-free technology with its groundbreaking Surface Plasmon-enhanced Common Path Interferometry (SPE) instrument, the ACCOLADE. […]